Phospho-Akt (S473) ?mouse Monoclonal Antibody(7F9)
應(yīng)用:WB 1:1000-2000, IHC 1:100-200?
產(chǎn)品名(Product Name)
Phospho-Akt (S473) mouse Monoclonal Antibody(7F9)
貨號(hào)(Catalog No.)
KL-15439
種類(Category)
Primary antibodies
宿主(Host)
Mouse
反應(yīng)種屬(Species specificity)
Human
應(yīng)用實(shí)驗(yàn)(Tested applications)
WB,IHC-p
克隆性(Clonality)
Monoclonal
偶連物(Conjugation)
Unconjugated
免疫原(Immunogen)
Synthetic Peptide of Phospho-Akt (S473) at AA range of 410-490
狀態(tài)(Form)
Liquid
儲(chǔ)存溶液(Buffer)
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
存放條件(Storage)
-20°C/1 year
純化方式(Purity)
The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
產(chǎn)品背景:AKT serine/threonine kinase 1(AKT1) Homo sapiens The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]?
特別提示:本公司的所有產(chǎn)品僅可用于科研實(shí)驗(yàn),嚴(yán)禁用于臨床醫(yī)療及其他非科研用途!?